Barring unforeseen events, core operating income is expected to grow mid- to high teens in constant currency, up from a prior view of low double-digit to mid-teens. Net sales are still expected to grow high single to low double-digit.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- NVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Options Volatility and Implied Earnings Moves This Week, July 15 – July 19, 2024
- Legend Biotech an attractive takeover target for biopharma, says Daiwa
- Novartis price target raised to CHF 103 from CHF 100 at Morgan Stanley
- Biotech Alert: Searches spiking for these stocks today